Inventor profile of:

Ling Yang

City:

Jiangsu

Country:

China

Published Applications:

12

Last publication date:

2021-07-22

Top Assignees for applications by Ling Yang

The entities that hold a legal rights for patent applications filed by inventor Yang Ling:

Recent patent applications by Yang Ling

Ling Yang from Jiangsu, CN has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2021-07-22
US20210220362A1
Human necessities

TLR7 agonist and pharmaceutical combination thereof for treating lung cancer

#2 | 2020-12-31
US20200405709A1
Human necessities

Quinoline derivative for treatment of triple-negative breast cancer

#3 | 2020-11-26
US20200368241A1
Human necessities

TLR7 AGONIST MALEATE SALT, CRYSTALLINE FORMS C, D AND E THEREOF, PREPARATION METHODS AND USES OF MALEATE SALT AND CRYSTALLINE FORMS

#4 | 2020-09-17
US20200291042A1
Chemistry; metallurgy

Macrocycle containing aminopyrazole and pyrimidine and pharmaceutical composition and use thereof

#5 | 2020-07-30
US20200239484A1
Chemistry; metallurgy

METHOD FOR PREPARING PYRROLO[3,2,-D]PYRIMIDINE COMPOUND, AND INTERMEDIATES THEREOF

#6 | 2020-07-30
US20200239454A1
Chemistry; metallurgy

Sulfonyl substituted bicyclic compound which acts as ROR inhibitor

#7 | 2019-10-03
US20190298712A1
Human necessities

Quinoline derivatives for non-small cell lung cancer

#8 | 2018-12-27
US20180370976A1
Chemistry; metallurgy

7-(thiazol-5-yl) pyrrolopyrimidine compound as TLR7 agonist

#9 | 2018-08-23
US20180235953A1
Human necessities

Methods and uses of quinoline derivatives in the treatment of soft tissue sarcomas and pharmaceutical compositions for treatment of same

#10 | 2018-04-26
US20180111950A1
Chemistry; metallurgy

Substituted amino six-membered saturated heteroalicycles as long-acting DPP-IV inhibitors

#11 | 2017-10-26
US20170304290A1
Human necessities

Quinoline derivative against non-small cell lung cancer

#12 | 2017-07-20
US20170202828A1
Human necessities

Methods and uses of quinoline derivatives in the treatment of soft tissue sarcomas and pharmaceutical compositions for treatment of same

InventorID:

1932251 ⎘